中外医疗2024,Vol.43Issue(9) :31-34.DOI:10.16662/j.cnki.1674-0742.2024.09.031

升降散加减治疗重症肺炎(痰热壅肺型)的效果及对炎症因子和外周血T淋巴细胞群的影响

Effects of addition and reduction of Shengjiangsan on Severe Pneumonia(Phlegm-heat Obstructing Lung Type)and on Inflammatory Factors and Peripheral Blood T Lymphocyte Population

薛彦霞 刘雨情 续自凤
中外医疗2024,Vol.43Issue(9) :31-34.DOI:10.16662/j.cnki.1674-0742.2024.09.031

升降散加减治疗重症肺炎(痰热壅肺型)的效果及对炎症因子和外周血T淋巴细胞群的影响

Effects of addition and reduction of Shengjiangsan on Severe Pneumonia(Phlegm-heat Obstructing Lung Type)and on Inflammatory Factors and Peripheral Blood T Lymphocyte Population

薛彦霞 1刘雨情 1续自凤1
扫码查看

作者信息

  • 1. 临沂市中医医院重症医学科,山东临沂 276000
  • 折叠

摘要

目的 探究痰热壅肺型重症肺炎患者应用升降散加减治疗的作用.方法 方便选取2022年1月—2023年12月临沂市中医医院收治的96例患者为研究对象,用信封法分为联合组和参照组,各48例.参照组行临床常规治疗方案,联合组加用升降散治疗,比较两组患者的临床疗效、症状缓解情况、炎症因子水平及免疫功能水平.结果 联合组治疗总有效率(97.92%)高于参照组(85.42%),差异有统计学意义(χ2=4.909,P<0.05).联合组发热、咳嗽、气促、咳痰、胸闷缓解时间短于参照组,差异有统计学意义(P均<0.05).干预后,联合组C反应蛋白、白细胞介素-6、肿瘤坏死因子、CD8+水平低于参照组,白细胞介素-10、CD3+、CD4+及CD4+/CD8+水平高于参照组,差异有统计学意义(P均<0.05).结论 痰热壅肺型重症肺炎患者应用升降散加减治疗可以提高疗效,缓解临床症状,降低炎症因子水平,加强免疫功能.

Abstract

Objective To explore the effect of addition and reduction of Shengjiangsan on severe pneumonia with phlegm-heat obstructing lung.Methods A total of 96 patients admitted to Linyi Hospital of Traditional Chinese Medi-cine from January 2022 to December 2023 were conveniently selected as the study objects and divided into a combina-tion group and a reference group by envelope method,with 48 cases in each group.The reference group received clini-cal routine treatment,and the combination group was treated with Tianxia powder.The clinical efficacy,symptom re-lief,inflammatory factor levels and immune function levels of the two groups were compared.Results The total effec-tive rate of treatment in combination group(97.92%)was higher than that in reference group(85.42%),the difference was statistically significant(χ2=4.909,P<0.05).The remission time of fever,cough,shortness of breath,expectoration and chest tightness in combination group were shorter than that in reference group,and the differences were statisti-cally significant(all P<0.05).After intervention,the levels of C-reactive protein,interleukin-6,tumor necrosis factor-α and CD8+in combination group were lower than those in reference group,while the levels of interleukin-10,CD3+,CD4+and CD4+/CD8+were higher than those in reference group,and the differences were statistically significant(all P<0.05).Conclusion The treatment of Shengjiangsan can improve the curative effect,relieve the clinical symptoms,re-duce the level of inflammatory factors and strengthen the immune function in the patients with severe pneumonia of phlegm-heat obstructing lung.

关键词

升降散加减治疗/重症肺炎/痰热壅肺型/临床疗效/炎症因子

Key words

Addition and reduction therapy/Severe pneumonia/Phlegm-heat obstructing lung type/Clinical effect/Inflammatory factors

引用本文复制引用

出版年

2024
中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
段落导航相关论文